The truncated adrenomedullin/adrenomedullin2 (ADM/ ADM2) analogs act as ADM/ADM2 antagonists to block CLR/RAMP signaling to prevent migraine pain and inhibit tumor growth/metastasis [30]. The gene discussed is DCLK3; the disease is migraine disorder.